Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05536401 · ClinicalTrials.gov registry record · NA
P200TE Agreement and Precision Study
A NA study, sponsored by Optos.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT05536401 is a NA study that was terminated before completion, run by Optos. The registered enrollment target is 15 participants.
The verdict
NCT05536401, a NA study, was terminated before completion, sponsored by Optos.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study is a prospective comparative, randomized, single center study to assess agreement and precision of the P200TE in comparison to the predicate device in normal subjects, subjects with glaucoma, and subjects with retinal disease.
Interventions
- DEVICE P200TE
- DEVICE Predicate Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-09-02 |
| Est. Completion | 2022-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05536401
The ClinicalTrials.gov registry entry for NCT05536401 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Optos, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which P200TE is the first listed.
NCT05536401 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05536401 about?
NCT05536401 is a clinical study titled "P200TE Agreement and Precision Study". This study is a prospective comparative, randomized, single center study to assess agreement and precision of the P200TE in comparison to the predicate device in normal subjects, subjects with glaucoma, and subjects with retinal disease.
What is the current status of trial NCT05536401?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2022-09-02. Estimated completion is 2022-09-20.
What interventions are being tested in trial NCT05536401?
The interventions under investigation include: P200TE (DEVICE), Predicate Device (DEVICE).
Who is sponsoring clinical trial NCT05536401?
This trial is sponsored by Optos, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.